Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Shares Outstanding (2016 - 2025)

Cartesian Therapeutics (RNAC) has disclosed Shares Outstanding for 2 consecutive years, with $17.9 million as the latest value for Q2 2016.

  • On a quarterly basis, Shares Outstanding changed N/A to $17.9 million in Q2 2016 year-over-year; TTM through Jun 2016 was $17.9 million, a N/A change, with the full-year FY2015 number at $2.2 million, changed N/A from a year prior.
  • Shares Outstanding was $17.9 million for Q2 2016 at Cartesian Therapeutics, up from $2.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $17.9 million in Q2 2016 to a low of $2.2 million in Q4 2015.